Concepedia

Ce Liang

CL

Statistics

Publications

4

Citations

328

H-Index

4

Active since

2000

Affiliations

Hebei University of Chinese Medicine(Current)

Hebei Medical University

Ce Liang is an author at Hebei University of Chinese Medicine specializing in rodent cerebral ischemia, medicine, and angiogenesis.

Publications per year

2000–2021

4

Publications

4

Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.

Dirk B. Mendel, Alexander Laird, Beverly D. Smolich et al. · PubMed · 2000 · 234 citations

Medicine, Oncology, Pharmacology +17

Astragaloside IV improves neurobehavior and promotes hippocampal neurogenesis in MCAO rats though BDNF-TrkB signaling pathway

Guangxiao Ni, Ce Liang, Jing Wang et al. · Biomedicine & Pharmacotherapy · 2020 · 51 citations · Full text

Medicine, Neuroscience, Pharmacology +17

RETRACTED: Astragaloside IV regulates the HIF/VEGF/Notch signaling pathway through miRNA-210 to promote angiogenesis after ischemic stroke

Ce Liang, Guangxiao Ni, Xuliang Shi et al. · Restorative Neurology and Neuroscience · 2020 · 31 citations

Life Sciences, Molecular Biology, Molecular Medicine +17

Modified Renshen Yangrong decoction enhances angiogenesis in ischemic stroke through promotion of MicroRNA‐210 expression by regulating the HIF/VEGF/Notch signaling pathway

Ce Liang, Teng Zhang, Xu‐Liang Shi et al. · Brain and Behavior · 2021 · 12 citations · Full text

Medicine, Molecular Medicine, Neurological Surgery +17

1–4 of 4